Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy Volunteers
Nitazoxanide use is limited by gastrointestinal side effects associated with increasing dose. In this drug repurposing study, we investigated the possibility of enhancing the exposure of its active metabolite, tizoxanide, through pharmacokinetic interaction with atazanavir/ritonavir. In this crossov...
Saved in:
Main Authors: | Abdulafeez Akinloye (Author), Timothy Oyedeji (Author), Oluwasegun Eniayewu (Author), Babatunde Adeagbo (Author), Oluseye Bolaji (Author), Steve Rannard (Author), Andrew Owen (Author), Adeniyi Olagunju (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester
by: Babajide Shenkoya, et al.
Published: (2021) -
The clinical antiprotozoal drug nitazoxanide and its metabolite tizoxanide extend Caenorhabditis elegans lifespan and healthspan
by: Wenfeng Li, et al.
Published: (2024) -
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir
by: Christiana Smith, et al.
Published: (2016) -
Bioequivalence of two oral formulations of nitazoxanide in healthy volunteers
by: Vinícius Marcondes REZENDE, et al.
Published: (2024) -
Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy
by: Shakir Atoyebi, et al.
Published: (2024)